Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jones, A M
Right arrow Articles by Webb, A K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jones, A M
Right arrow Articles by Webb, A K
Thorax 2003;58:525-527
© 2003 BMJ Publishing Group & British Thoracic Society


CYSTIC FIBROSIS

Identification of airborne dissemination of epidemic multiresistant strains of Pseudomonas aeruginosa at a CF centre during a cross infection outbreak

A M Jones1, J R W Govan3, C J Doherty3, M E Dodd1, B J Isalska2, T N Stanbridge2, A K Webb1

1 Adult Cystic Fibrosis Centre, Wythenshawe Hospital, Manchester M23 9LT, UK
2 Medical Microbiology, Wythenshawe Hospital, Manchester M23 9LT, UK
3 Medical Microbiology, Medical School, University of Edinburgh, Edinburgh EH8 9AG, UK

Correspondence to:
Correspondence to:
Dr A M Jones, Adult Cystic Fibrosis Centre, Wythenshawe Hospital, Southmoor Road, Manchester M23 9LT, UK;
andmarkj{at}hotmail.com


ABSTRACT
Background: Chronic Pseudomonas aeruginosa infection is a major cause of morbidity and mortality for individuals with cystic fibrosis (CF). P aeruginosa cross infection outbreaks have recently been reported at CF holiday camps and specialist centres. The mechanism of cross infection is unknown. A study was performed to look for the presence of epidemic strains of P aeruginosa in the environment of a CF centre during a cross infection outbreak and to examine their potential modes of spread between patients.

Methods: Microbiological sampling of the environment of the CF facility was performed, including room air sampling. Individual P aeruginosa strains were identified by bacterial fingerprinting. The typing patterns were compared with those of epidemic strains responsible for cross infection among the patients.

Results: Epidemic P aeruginosa strains were isolated from room air when patients performed spirometric tests, nebulisation, and airway clearance, but were not present in other areas of the inanimate environment of the CF centre.

Conclusions: Aerosol dissemination may be the most important factor in patient-to-patient spread of epidemic strains of P aeruginosa during recent cross infection outbreaks at adult CF centres.


Keywords: cystic fibrosis; cross infection; Pseudomonas aeruginosa




This article has been cited by other articles:


Home page
JRSMHome page
S. Conway
Segregation is good for patients with cystic fibrosis
J R Soc Med, July 1, 2008; 101(Supplement_1): 31 - 35.
[Full Text] [PDF]


Home page
Eur Respir JHome page
P. Schelstraete, S. Van daele, K. De Boeck, M. Proesmans, P. Lebecque, J. Leclercq-Foucart, A. Malfroot, M. Vaneechoutte, and F. De Baets
Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients
Eur. Respir. J., April 1, 2008; 31(4): 822 - 829.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
D. T. Kenna, C. J. Doherty, J. Foweraker, L. Macaskill, V. A. Barcus, and J. R. W. Govan
Hypermutability in environmental Pseudomonas aeruginosa and in populations causing pulmonary infection in individuals with cystic fibrosis
Microbiology, June 1, 2007; 153(6): 1852 - 1859.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
D. Chambers, F. Scott, R. Bangur, R. Davies, A. Lim, S. Walters, G. Smith, T. Pitt, D. Stableforth, and D. Honeybourne
Factors associated with infection by Pseudomonas aeruginosa in adult cystic fibrosis
Eur. Respir. J., October 1, 2005; 26(4): 651 - 656.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
S. G. Van daele, H. Franckx, R. Verhelst, P. Schelstraete, F. Haerynck, L. Van Simaey, G. Claeys, M. Vaneechoutte, and F. de Baets
Epidemiology of Pseudomonas aeruginosa in a cystic fibrosis rehabilitation centre
Eur. Respir. J., March 1, 2005; 25(3): 474 - 481.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. M. Jones, M. E. Dodd, J. R. W. Govan, C. J. Doherty, C. M. Smith, B. J. Isalska, and A. K. Webb
Prospective Surveillance for Pseudomonas aeruginosa Cross-Infection at a Cystic Fibrosis Center
Am. J. Respir. Crit. Care Med., February 1, 2005; 171(3): 257 - 260.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M.R. O'Carroll, M.W. Syrmis, C.E. Wainwright, R.M. Greer, P. Mitchell, C. Coulter, T.P. Sloots, M.D. Nissen, and S.C. Bell
Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units
Eur. Respir. J., July 1, 2004; 24(1): 101 - 106.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
F. W. Scott and T. L. Pitt
Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales
J. Med. Microbiol., July 1, 2004; 53(7): 609 - 615.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2003 BMJ Publishing Group Ltd & British Thoracic Society